These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29096643)

  • 41. A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods.
    Hokimoto N; Sugimoto T; Namikawa T; Funakoshi T; Oki T; Ogawa M; Fukuhara H; Inoue K; Sato T; Hanazaki K
    Oncology; 2018; 94(2):99-106. PubMed ID: 29131021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis.
    Sugie T; Ikeda T; Kawaguchi A; Shimizu A; Toi M
    Int J Clin Oncol; 2017 Feb; 22(1):11-17. PubMed ID: 27864624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
    Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
    Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer.
    Schaafsma BE; Verbeek FP; Rietbergen DD; van der Hiel B; van der Vorst JR; Liefers GJ; Frangioni JV; van de Velde CJ; van Leeuwen FW; Vahrmeijer AL
    Br J Surg; 2013 Jul; 100(8):1037-44. PubMed ID: 23696463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging.
    Gilmore DM; Khullar OV; Jaklitsch MT; Chirieac LR; Frangioni JV; Colson YL
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):562-70; discussion 569-70. PubMed ID: 23790404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tumours.
    Wan J; Oblak ML; Ram A; Singh A; Nykamp S
    Vet Comp Oncol; 2021 Jun; 19(2):295-303. PubMed ID: 33403753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green--human serum albumin in comparison with gamma emitting radioactive colloid tracer.
    Polom K; Murawa D; Nowaczyk P; Rho YS; Murawa P
    Eur J Surg Oncol; 2012 Feb; 38(2):137-42. PubMed ID: 22130469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye.
    Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
    Tumour Biol; 2014 Apr; 35(4):3073-8. PubMed ID: 24307620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid Indocyanine Green-
    Dell'Oglio P; de Vries HM; Mazzone E; KleinJan GH; Donswijk ML; van der Poel HG; Horenblas S; van Leeuwen FWB; Brouwer OR
    Eur Urol; 2020 Dec; 78(6):865-872. PubMed ID: 32950298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
    Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
    Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sentinel Lymph Node Procedure in Pediatric Patients with Melanoma, Squamous Cell Carcinoma, or Sarcoma Using Near-Infrared Fluorescence Imaging with Indocyanine Green: A Feasibility Trial.
    Jeremiasse B; van Scheltinga CEJT; Smeele LE; Tolboom N; Wijnen MHWA; van der Steeg AFW
    Ann Surg Oncol; 2023 Apr; 30(4):2391-2398. PubMed ID: 36641516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study.
    Baeten IGT; Hoogendam JP; Braat AJAT; Veldhuis WB; Jonges GN; Jürgenliemk-Schulz IM; Zweemer RP; Gerestein CG
    BMJ Open; 2022 Sep; 12(9):e061829. PubMed ID: 36100304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma.
    Gilmore DM; Khullar OV; Gioux S; Stockdale A; Frangioni JV; Colson YL; Russell SE
    Ann Surg Oncol; 2013 Jul; 20(7):2357-63. PubMed ID: 23440551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-Time
    Wang Z; Yang X; Wang J; Liu P; Pan Y; Han C; Pei J
    Front Oncol; 2021; 11():621914. PubMed ID: 34026607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer.
    Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
    JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.